Thalidomide Survivors Contribution Program (February 2016)

Description of Program

The Thalidomide Survivors Contribution Program provides financial support to Canadian Thalidomide Survivors. The Program is delivered by Health Canada through a contribution agreement with a third party administrator.

Why was a Privacy Impact Assessment (PIA) completed?

This PIA was completed as personal information is used to make administrative decisions about financial support to Canadian Thalidomide Survivors.

The PIA examines the privacy-related risks of the Thalidomide Survivors Contribution Program and proposes methods to lower these risks.

More Information

This PIA focused on Health Canada’s collection, use, disclosure and retention and disposition of personal information involved in the Program’s business processes. It did not include an examination of privacy practices of the third party administrator.

The PIA identified risks pertaining to control and disclosure of records, sharing of information within Health Canada, retention and disposition authorities, maintaining accuracy and the absence of a Personal Information Bank (PIB), which is currently being implemented.

If you would like more information about this Privacy Impact Assessment (PIA) please contact:

Health Canada / Public Health Agency of Canada Privacy Management Division (PMD)
Holland Cross - Tower B
1600 Scott Street, 4th Floor, Suite 410B
Postal Locator: 3107A
Ottawa, Ontario K1A 0K9
E-mail: privacy-vie.privee@hc-sc.gc.ca
Telephone: 613-946-3179
Fax: 613-941-4541
Teletypewriter: 1-800-465-7735 (Service Canada)

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: